Invitation to attend a live Elekta Unity treatment at University Hospital Tübingen
Having conducted 1,400 fractions on an Elekta Unity system, Prof. Dr. Zips presents his experienceSTOCKHOLM, October 24, 2019 – Elekta (EKTA-B.ST) invites financial analysts and investors to Tübingen on November 29 for an update on the use of Elekta Unity and a better understanding of the clinical possibilities of the MR-Linac.Based on the delivery of 1,400 fractions and treating almost 100 patients with Elekta Unity, Prof. Dr. Daniel Zips, Medical Director of Department of Radiation Oncology, University Hospital Tübingen & Director of Comprehensive Cancer Center Tübingen-Stuttgart, will